Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Sleep Disorders

  Free Subscription

Articles published in Lancet

Retrieve available abstracts of 9 articles:
HTML format

Single Articles

    January 2021
  1. HUANG C, Huang L, Wang Y, Li X, et al
    6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
    Lancet. 2021 Jan 8. pii: S0140-6736(20)32656.
    PubMed     Abstract available

    June 2020
  2. EERDEKENS R, Bouwmeester S
    Atrial septal defect and haemodynamic consequences of continuous positive airway pressure treatment.
    Lancet. 2020;395:1864.

    March 2019
  3. MASA JF, Mokhlesi B, Benitez I, Gomez de Terreros FJ, et al
    Long-term clinical effectiveness of continuous positive airway pressure therapy versus non-invasive ventilation therapy in patients with obesity hypoventilation syndrome: a multicentre, open-label, randomised controlled trial.
    Lancet. 2019 Mar 29. pii: S0140-6736(18)32978.
    PubMed     Abstract available

  4. MURPHY PB, Piper AJ, Hart N
    Obesity hypoventilation syndrome: is less really more?
    Lancet. 2019 Mar 29. pii: S0140-6736(19)30248.

    September 2018
  5. RIEMANN D, Espie C
    Evidence-based psychological therapies for insomnia.
    Lancet. 2018;392:735.

    July 2018
  6. LIGHT M, Orr JE, Malhotra A, Owens RL, et al
    Continuous positive airway pressure device detects atrial fibrillation induced central sleep apnoea.
    Lancet. 2018;392:160.

    June 2018
  7. WHITEHEAD K, Beaumont M
    Insomnia: a cultural history.
    Lancet. 2018;391:2408-2409.

    September 2016
  8. ARZT M
    Neurostimulation in patients with heart failure and central sleep apnoea.
    Lancet. 2016;388:938-40.

  9. COSTANZO MR, Ponikowski P, Javaheri S, Augostini R, et al
    Transvenous neurostimulation for central sleep apnoea: a randomised controlled trial.
    Lancet. 2016;388:974-82.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Sleep Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.